<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110808">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01722565</url>
  </required_header>
  <id_info>
    <org_study_id>LAP-APR-2012-028</org_study_id>
    <nct_id>NCT01722565</nct_id>
  </id_info>
  <brief_title>Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection</brief_title>
  <official_title>Randomized, Controlled, Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <authority>Spain: Comité Ético de Investigación Clínica</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: parastomal hernia (PH) is a frequent complication after an ostomy, despite the
      many prevention and treatment techniques that have been described. Since the introduction of
      laparoscopy, the frequency of PH is even higher than in open surgery. This type of hernia
      remains a surgical problem of considerable importance, requiring significant consumption of
      public health and economic resources, and representing a major alteration of the quality of
      life of these patients.

      Objective: to evaluate the effectiveness of the insertion of a prosthesis to prevent PH in
      elective surgery for laparoscopic abdominoperineal resection.

      Methodology: prospective, multidisciplinary, multi-center randomized controlled study.
      Control group: Rectal neoplasms undergoing elective surgery for laparoscopic
      abdominoperineal resection. Study group: Rectal neoplasms undergoing elective surgery for
      laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and
      poliglecaprone 25). Sample size was calculated based on a proportion of parastomal hernia of
      65% in the control group and 15% in the study group. With an α risk =0.05 and 1- β= 0.8, 28
      patients are required, 14 per group. Estimating a drop-out rate of 10%, the final number
      will be 32 patients. The efficacy will be evaluated clinically at six months and abdominal
      CT will be performed at 12 months along with another clinical evaluation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The reduction in the incidence of Parastomal Hernia after the mesh placement</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Parastomal Hernia</condition>
  <arm_group>
    <arm_group_label>Mesh Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving conventional sigmoid end colostomy plus a preperitoneal lightweight mesh Physiomesh® by laparoscopic procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receiving conventional sigmoid end colostomy by laparoscopic procedure, without mesh</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25)</intervention_name>
    <arm_group_label>Mesh Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of either sex intervened electively for colorectal surgery (rectal cancer)
             in whom definitive colostomy is indicated after laparoscopic abdominoperineal
             amputation.

          -  Life expectancy above  12 months

        Exclusion Criteria:

          -  - Patients with allergy or intolerance of the compounds in the mesh

          -  Carriers of prosthetic meshes in the area of the ostomy

          -  Patients electively intervened for colorectal surgery (neo de reco) in whom
             definitive colostomy is indicated after abdominoperineal amputation but not via a
             laparoscopic approach.

          -  Cirrhotic patients

          -  Patients with life expectancy below 12 months due to underlying disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Serra-Aracil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporacion Sanitaria Universitaria Parc Tauli</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Lopez-Cano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vall d'Hebron</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Serra-Aracil, MD</last_name>
    <phone>34-93-723-1010</phone>
    <phone_ext>21490</phone_ext>
    <email>jserraa@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Corporacion Sanitaria Universitaria Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Serra-Aracil, MD</last_name>
      <phone>+34937231010</phone>
      <phone_ext>21490</phone_ext>
      <email>jserraa@tauli.cat</email>
    </contact>
    <investigator>
      <last_name>Xavier Serra-Aracil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Lopez-Cano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 7, 2012</lastchanged_date>
  <firstreceived_date>November 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Xavier Serra-Aracil</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Parastomal hernias</keyword>
  <keyword>Tolerance of lightweight meshes</keyword>
  <keyword>laparoscopic abdominoperineal resection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
